- Home
- CNTA vs NVST Comparison
CNTA vs NVST Comparison
Compare CNTA & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | NVST |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.6B |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNTA | NVST |
|---|---|---|
| Price | $25.33 | $21.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $37.70 | $21.17 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $15,000,000.00 | ★ $2,621,800,000.00 |
| Revenue This Year | N/A | $7.42 |
| Revenue Next Year | N/A | $3.60 |
| P/E Ratio | ★ N/A | $255.66 |
| Revenue Growth | ★ 118.88 | 4.73 |
| 52 Week Low | $9.60 | $14.22 |
| 52 Week High | $30.58 | $22.68 |
Technical Indicators
Market Signals| Indicator | CNTA | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 42.85 | 60.18 |
| Support Level | $24.17 | $21.69 |
| Resistance Level | $26.01 | $22.67 |
| Average True Range (ATR) | 1.20 | 0.60 |
| MACD | -0.37 | 0.02 |
| Stochastic Oscillator | 19.03 | 75.54 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.